Sanket Koul
Sanket Koul
Trump on Wednesday called India's tariffs on US exports among the highest in the world, with the most strenuous non-monetary trade barriers of any country, in a post on Truth Social
Nathealth has proposed a digital single-window system to Niti Aayog to ease the healthcare sector's compliance load, citing inefficiencies and duplication across ministries
Torrent Pharmaceuticals reports Rs 548 crore Q1 net profit, led by strong growth in India, the US, and Brazil, with chronic therapies and top brands driving momentum
The Hyderabad based firm aims to raise ₹353.4 crore through a fresh issue of equity shares. Market sources claim the total issue size could touch ₹2000 crore
This comes a day after a portion of a government school in Rajasthan's Jhalawar district collapsed on Friday, killing seven children and leaving 28 injured
Rising infertility, delayed motherhood and increased awareness are driving demand for egg freezing across India, with clinics reporting a surge in inquiries from urban women
Elan Group's strategic debt repayment strengthens its financial position, creating room for investment in future projects and land acquisitions
Expected to be closed in 4 months, deal to facilitate Indian firm's entry into Africa
Under the agreement, Fortis will manage operations of six Gleneagles hospitals and one clinic, earning a monthly fee and expanding its bed capacity and national presence
It recommended implementation of integrated urban flood risk management at national and state levels, with sustainable stormwater management at city level, along with heat mitigation actions
According to the EoI, ICMR-RMRCBB will also provide expert guidance and technical support for the production of the vaccine in all phases
CDSCO has flagged four drugs as spurious and 185 others as not of standard quality for June 2025. The list includes antibiotics and heart disease medications. Investigations are underway
The CDSCO has updated its guidelines for issuing export NOCs for new drug formulations, including relaxations for FDCs, research-oriented drug batches, and SRA approvals
Pharma firms get time till August 15 to file COPP applications online via ONDLS as CDSCO addresses onboarding challenges and industry pleas
KPMG-FHRAI report projects India's medical tourism to reach $58.2 bn by 2035, calls for tax incentives, global branding and startup support to drive growth
San Diego varsity cites regulatory and cost barriers for pausing its GIFT City campus and will now expand in India through hybrid degrees, MoUs and online Master's programmes
The Gurugram campus marks the first operational foreign university in India under NEP 2020 reforms, offering UK-aligned UG and PG courses and enabling student mobility
While price revision lists by the National Pharmaceutical Pricing Authority (NPPA) include several diabetes drugs, combinations of empagliflozin have been prominently mentioned in past three months
Emcure to distribute and promote Sanofi's oral anti-diabetic brands Amaryl and Cetapin in India, expanding access amid rising prevalence of uncontrolled diabetes
Indira IVF refiles DRHP after earlier withdrawal, as investor interest grows in India's ART sector; aims for Rs 3,500 crore IPO, joins peers like Swiggy and Meesho